Gloria Melanie 4
4 · Immunovant, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Gloria Melanie
Chief Operating Officer
Transactions
- Award
Common Stock
2024-11-18+109,956→ 109,956 total - Award
Stock Option (right to buy)
2024-11-18+137,446→ 137,446 totalExercise: $25.51Exp: 2034-11-18→ Common Stock (137,446 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on November 18, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]This option was granted pursuant to the Issuer's 2019 Equity Incentive Plan. The shares underlying the option will vest as to 25% of the shares on November 18, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.